Add BrightSurf on Google Email

Diabetologia


Global survey suggests patients most with type 1 diabetes that have adapted to remote medical appointments would continue this post COVID-19 pandemic

A global survey of over 7,000 patients with type 1 diabetes found that three-quarters would continue using online or telephone appointments with their doctors. Glucose control was positively associated with a positive perception of telemedicine, and age and education level did not appear to influence perceptions.

Study shows that control of blood sugar levels improved among people with type 1 diabetes who stopped working during lockdown

Among individuals with type 1 diabetes, those who stopped working during lockdown experienced improved blood sugar levels. This improvement was attributed to reduced opportunities for exercise and heightened psychological stress being replaced by a more regular lifestyle and increased focus on diabetes management.

SourceDiabetologia·JournalDiabetes Therapy·DateSep 22, 2020

Study suggests the average person with type 1 diabetes will live almost 8 years less, and those with type 2 diabetes almost 2 years less, than people in the general population

A new study suggests that people with type 1 diabetes will live almost 8 years less and those with type 2 diabetes will live almost 2 years less than the general population. The study used data from the UK National Diabetes Audit and Office for National Statistics to calculate life expectancy, finding a significant gap in mortality rat...

SourceDiabetologia·JournalCardiovascular Endocrinology & Metabolism·DateSep 21, 2020

Insomnia identified as a new risk factor for type 2 diabetes in new study which also confirms many other risk and protective factors

A new study confirms insomnia as a novel risk factor for type 2 diabetes, with individuals experiencing a 17% higher likelihood of developing the condition. The research also identifies 15 protective factors, including increased total cholesterol and testosterone levels, which can help inform public health policies to prevent the disease.

SourceDiabetologia·JournalDiabetologia·DateSep 8, 2020

New research shows that increasing number of lost pregnancies is linked to higher risk of developing type 2 diabetes

A new study published in Diabetologia found that women who experience more pregnancy losses are at a higher risk of developing type 2 diabetes. The study analyzed data from over 247,000 women and found that each additional pregnancy loss increased the risk by 18-71%. Women with no previous pregnancies also had a significantly higher risk.

SourceDiabetologia·JournalDiabetologia·DateMay 20, 2020

Study links frequent tooth brushing to lower risk of diabetes while dental disease and missing teeth associated with increased risk; stronger effect of tooth brushing in younger adults and women

A study published in Diabetologia found that frequent tooth brushing is linked to a lower risk of developing diabetes, with an 8% reduced risk for those brushing three times a day or more. In contrast, dental disease and missing teeth are associated with a higher risk of diabetes, with increases of 9% and 21% respectively.

SourceDiabetologia·JournalDiabetologia·DateMar 2, 2020

Preterm birth linked to increased rates of diabetes in children and young adults, with certain effects stronger in females

New research reveals a significant association between preterm birth and an increased risk of developing type 1 and type 2 diabetes in children and young adults. Women born preterm are particularly at higher risk, with a 30% increase in type 2 diabetes risk and a 60% increase in type 1 diabetes risk compared to their male counterparts.

SourceDiabetologia·JournalDiabetologia·DateDec 5, 2019

Study shows both natural variation in ACE concentrations and lowering blood pressure with ACE inhibitors are associated with lower risk of type 2 diabetes

A new study found that using ACE inhibitors to lower blood pressure is associated with a 24% reduced risk of developing type 2 diabetes. Natural genetic variations in ACE concentrations are also linked to lower T2D risk. The researchers used Mendelian randomization to infer the causal effects of ACE inhibition on T2D risk.

New research shows dapagliflozin used to treat diabetes can also

Research suggests dapagliflozin can reduce death and hospitalization rates in patients with heart failure, as well as improve health-related quality of life. The study found a 26% reduced risk of primary outcome in the dapagliflozin group compared to placebo, with benefits seen in both patients with and without type 2 diabetes.

SourceDiabetologia·JournalNew England Journal of Medicine·DateSep 19, 2019

UK study shows increasing proportion of younger adults with type 2 diabetes, with younger cases having a worse metabolic profile

A UK study found that the proportion of younger adults diagnosed with type 2 diabetes has increased since the start of the century. Younger cases have a more aggressive metabolic profile, including higher BMI, blood glucose levels, and cholesterol levels. This trend is associated with a higher risk of cardiovascular disease and mortality.